Noxopharm Ltd has released a press release.
Amendment to Preliminary Final Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Noxopharm
- Preliminary Final Report
- Noxopharm to Initiate Radiotherapy Clinical Studies
- Noxopharm Provides Update on Inaugural Clinical Study
- ASX Market Release - Admission to Official List
Later from Noxopharm
- Initial Clinic Study Announced and Approved
- Breakthrough in Delivering Idronoxil into Brain
- First NOX66 Clinical Trial to Commence
- Brain Cancer Study Commences
- NOX researching rare Abscopal Response
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm